PTE News and Press, PolarityTE Inc. From 10/24/19

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will report calendar third quarter 2019 financial results by press release on Tuesday, November 12, 2019 at approximately 4:00 p.m. E...

PolarityTE (NASDAQ: PTE ) is off 5% postmarket after the disclosure that stockholder Dr. Denver Lough is offering up to 7.05M shares . More news on: PolarityTE, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Editor's note: Seeking Alpha is proud to welcome Et al BioCapital as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more » Editor's note: S...

Thinly traded nano cap PolarityTE (NASDAQ: PTE ) is up  8%  premarket on light volume in reaction to positive results from an open-label single-arm pilot study evaluating SkinTE for closing venous stasis leg ulcers (VLUs) that have not responded to convention treatments. The data...

Open-label, single-arm pilot study concluded SkinTE demonstrated an 80 percent overall wound closure rate within 12 weeks Median time to closure for cohort was 21 days Prospective multi-center, randomized controlled trial (NCT03881267), designed from this pilot, will further ...

The following slide deck was published by PolarityTE, Inc. in conjunction with this Read more ...

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that two abstracts demonstrating the impact of the Company’s SkinTE™ product in treating diabetes-related wounds were accepte...

The Right is turning “nationalist,” the Left is turning “socialist,” and the US is foisting a trade war on the world which no one wants. Does that sound like the 1930s to you? Because it sounds like the 1930s to me. - A very unfunny joke I’ve been telli...

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that Nikolai Sopko, MD, PhD, Chief Scientific Officer of PolarityTE, was selected to present at the annual Cell & Gene Meeting on the M...

Plus Therapeutics (NASDAQ: PSTV ) +99%  on BARDA payment . More news on: Plus Therapeutics, Inc., Avadel Pharmaceuticals plc, Arotech Corporation, Stocks on the move, Read more ...